AVX 0.00% 2.5¢ avexa limited

re: chance of failing? avexa 754 on previous phase ll data...

  1. 59 Posts.
    re: chance of failing? avexa 754 on previous phase ll data achieved a 25 fold decrease in viral load on a non mutated hiv. (shire did this trial)

    usually mutated is 2x as hard to kill

    requires a 4 fold decrease in mutated HIV to pass phase ll

    should be ok
 
watchlist Created with Sketch. Add AVX (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.